Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019
BackgroundThe exponential growth of the cancer burden attributable to metabolic factors deserves global attention. We investigated the trends of cancer mortality attributable to metabolic factors in 204 countries and regions between 1990 and 2019.MethodsWe extracted data from the Global Burden of Di...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1032749/full |
_version_ | 1797948082678136832 |
---|---|
author | Yan Zhang Yuwei Ding Yuwei Ding Ning Zhu Ning Zhu Mi Mi Mi Mi Yier Lu Yier Lu Jia Zheng Shanshan Weng Ying Yuan Ying Yuan Ying Yuan |
author_facet | Yan Zhang Yuwei Ding Yuwei Ding Ning Zhu Ning Zhu Mi Mi Mi Mi Yier Lu Yier Lu Jia Zheng Shanshan Weng Ying Yuan Ying Yuan Ying Yuan |
author_sort | Yan Zhang |
collection | DOAJ |
description | BackgroundThe exponential growth of the cancer burden attributable to metabolic factors deserves global attention. We investigated the trends of cancer mortality attributable to metabolic factors in 204 countries and regions between 1990 and 2019.MethodsWe extracted data from the Global Burden of Disease Study (GBD) 2019 and assessed the mortality, age-standardized death rate (ASDR), and population attributable fractions (PAFs) of cancers attributable to metabolic factors. Average annual percentage changes (AAPCs) were calculated to assess the changes in the ASDR. The cancer mortality burden was evaluated according to geographic location, SDI quintiles, age, sex, and changes over time.ResultsCancer attributable to metabolic factors contributed 865,440 (95% UI, 447,970-140,590) deaths in 2019, a 167.45% increase over 1990. In the past 30 years, the increase in the number of deaths and ASDR in lower SDI regions have been significantly higher than in higher SDI regions (from high to low SDIs: the changes in death numbers were 108.72%, 135.7%, 288.26%, 375.34%, and 288.26%, and the AAPCs were 0.42%, 0.58%, 1.51%, 2.36%, and 1.96%). Equatorial Guinea (AAPC= 5.71%), Cabo Verde (AAPC=4.54%), and Lesotho (AAPC=4.42%) had the largest increase in ASDR. Large differences were observed in the ASDRs by sex across different SDIs, and the male-to-female ratios of ASDR were 1.42, 1.50, 1.32, 0.93, and 0.86 in 2019. The core population of death in higher SDI regions is the age group of 70 years and above, and the lower SDI regions are concentrated in the age group of 50-69 years. The proportion of premature deaths in lower SDI regions is significantly higher than that in higher SDI regions (from high to low SDIs: 2%, 4%, 7%, 7%, and 9%). Gastrointestinal cancers were the core burden, accounting for 50.11% of cancer deaths attributable to metabolic factors, among which the top three cancers were tracheal, bronchus, and lung cancer, followed by colon and rectum cancer and breast cancer.ConclusionsThe cancer mortality burden attributable to metabolic factors is shifting from higher SDI regions to lower SDI regions. Sex differences show regional heterogeneity, with men having a significantly higher burden than women in higher SDI regions but the opposite is observed in lower SDI regions. Lower SDI regions have a heavier premature death burden. Gastrointestinal cancers are the core of the burden of cancer attributable to metabolic factors. |
first_indexed | 2024-04-10T21:37:50Z |
format | Article |
id | doaj.art-2e2c623ba22b4f879091fb6f564c7d21 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-10T21:37:50Z |
publishDate | 2023-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-2e2c623ba22b4f879091fb6f564c7d212023-01-19T08:55:39ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-01-011310.3389/fonc.2023.10327491032749Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019Yan Zhang0Yuwei Ding1Yuwei Ding2Ning Zhu3Ning Zhu4Mi Mi5Mi Mi6Yier Lu7Yier Lu8Jia Zheng9Shanshan Weng10Ying Yuan11Ying Yuan12Ying Yuan13Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaDepartment of Medical Geriatrics, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaCancer Center, Zhejiang University, Hangzhou, Zhejiang, ChinaBackgroundThe exponential growth of the cancer burden attributable to metabolic factors deserves global attention. We investigated the trends of cancer mortality attributable to metabolic factors in 204 countries and regions between 1990 and 2019.MethodsWe extracted data from the Global Burden of Disease Study (GBD) 2019 and assessed the mortality, age-standardized death rate (ASDR), and population attributable fractions (PAFs) of cancers attributable to metabolic factors. Average annual percentage changes (AAPCs) were calculated to assess the changes in the ASDR. The cancer mortality burden was evaluated according to geographic location, SDI quintiles, age, sex, and changes over time.ResultsCancer attributable to metabolic factors contributed 865,440 (95% UI, 447,970-140,590) deaths in 2019, a 167.45% increase over 1990. In the past 30 years, the increase in the number of deaths and ASDR in lower SDI regions have been significantly higher than in higher SDI regions (from high to low SDIs: the changes in death numbers were 108.72%, 135.7%, 288.26%, 375.34%, and 288.26%, and the AAPCs were 0.42%, 0.58%, 1.51%, 2.36%, and 1.96%). Equatorial Guinea (AAPC= 5.71%), Cabo Verde (AAPC=4.54%), and Lesotho (AAPC=4.42%) had the largest increase in ASDR. Large differences were observed in the ASDRs by sex across different SDIs, and the male-to-female ratios of ASDR were 1.42, 1.50, 1.32, 0.93, and 0.86 in 2019. The core population of death in higher SDI regions is the age group of 70 years and above, and the lower SDI regions are concentrated in the age group of 50-69 years. The proportion of premature deaths in lower SDI regions is significantly higher than that in higher SDI regions (from high to low SDIs: 2%, 4%, 7%, 7%, and 9%). Gastrointestinal cancers were the core burden, accounting for 50.11% of cancer deaths attributable to metabolic factors, among which the top three cancers were tracheal, bronchus, and lung cancer, followed by colon and rectum cancer and breast cancer.ConclusionsThe cancer mortality burden attributable to metabolic factors is shifting from higher SDI regions to lower SDI regions. Sex differences show regional heterogeneity, with men having a significantly higher burden than women in higher SDI regions but the opposite is observed in lower SDI regions. Lower SDI regions have a heavier premature death burden. Gastrointestinal cancers are the core of the burden of cancer attributable to metabolic factors.https://www.frontiersin.org/articles/10.3389/fonc.2023.1032749/fullglobal burden of disease study (GBD)cancermortalityage standardized rate (ASR)average annual percentage change (AAPC) |
spellingShingle | Yan Zhang Yuwei Ding Yuwei Ding Ning Zhu Ning Zhu Mi Mi Mi Mi Yier Lu Yier Lu Jia Zheng Shanshan Weng Ying Yuan Ying Yuan Ying Yuan Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019 Frontiers in Oncology global burden of disease study (GBD) cancer mortality age standardized rate (ASR) average annual percentage change (AAPC) |
title | Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019 |
title_full | Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019 |
title_fullStr | Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019 |
title_full_unstemmed | Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019 |
title_short | Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019 |
title_sort | emerging patterns and trends in global cancer burden attributable to metabolic factors based on the global burden of disease study 2019 |
topic | global burden of disease study (GBD) cancer mortality age standardized rate (ASR) average annual percentage change (AAPC) |
url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1032749/full |
work_keys_str_mv | AT yanzhang emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT yuweiding emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT yuweiding emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT ningzhu emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT ningzhu emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT mimi emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT mimi emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT yierlu emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT yierlu emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT jiazheng emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT shanshanweng emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT yingyuan emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT yingyuan emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 AT yingyuan emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019 |